Mayo Clinic 的途径

妙佑医疗国际的医生在使用骨髓移植治疗多种病症(包括癌症)方面拥有丰富的经验。妙佑医疗国际使用患者自身的细胞(自体移植)、供体的细胞(同种异体移植)或脐带的细胞(脐带血移植)为成人和儿童提供骨髓移植。

致力于提供患者所需护理的医护人员为选择妙佑医疗国际的患者提供全面、体贴和个性化关怀。此外,妙佑医疗国际在亚利桑那州、佛罗里达州和明尼苏达州的院区提供了多个支持小组 。

团队合作

在妙佑医疗国际,专门从事血液疾病的医生(血液科医生)与其他专家组成一个多学科团队,为接受骨髓移植的成人和儿童提供个性化的全人护理。

骨髓移植的图像

移植团队可能包括血液专科医师、癌症专科医师(肿瘤医生)、心理健康专科医师(心理医生和精神科医生)、骨髓移植计划协调员、输血科护士、训练有素的专业护士、医师助理、社工、护士协调员、临床护理专业人员、营养师、药剂师、牧师和儿童医疗辅导师(针对接受骨髓移植患儿)。

接受骨髓移植的儿童和青少年患者在妙佑医疗国际明尼苏达州院区内的儿童中心接受治疗。在妙佑医疗国际的亚利桑那州院区,妙佑医疗国际的儿科专家与凤凰城儿童医院共同合作,为年幼患者提供医护。他们共同监管同一个儿童骨髓移植项目。妙佑医疗国际佛罗里达州院区的专家与 Nemours 儿童专科护理中心和 Wolfson 儿童医院共同合作为患儿提供医护。

妙佑医疗国际的医生和工作人员相互协作的图片 携手合作

妙佑医疗国际的医生和工作人员会通力合作为您提供最能满足您需求的诊疗护理服务。

经验

妙佑医疗国际的医生在为患有各种癌症和非癌性疾病的成人和儿童进行骨髓移植方面具有丰富的经验。每年约有 800 名患者在妙佑医疗国际接受骨髓移植。

1963 年,妙佑医疗国际进行了第一例骨髓移植手术。妙佑医疗国际在亚利桑那州、佛罗里达州和明尼苏达州院区的医生均可进行骨髓移植手术。

妙佑医疗国际进行骨髓移植的历史悠久,这意味着医生具备丰富的知识和资源,可为您提供专家级的个性化护理。

提供体贴照护的工作人员 提供体贴照护

妙佑医疗国际的专家利用其丰富的经验,为考虑骨髓移植的患者提供个性化的护理。

将研究进展应用到患者护理中

妙佑医疗国际的医生和科学家们参与了前沿研究,确保医生能够将最新的技术应用到患者护理中。

创新技术包括:

  • 半相合移植。这种移植使用的干细胞来自非完美配型的供体。研究正在帮助医生了解如何减少其干细胞供体并非完美配型的患者的并发症风险,并改善其康复过程。
  • 减低剂量预处理。在移植前使用低剂量化疗和放疗可使老年患者和身体不够健康的患者接受骨髓移植。
  • 脐带血移植。这种移植使用了储存和冷冻的脐带血。脐带血中的干细胞较少,但这些干细胞能够比骨髓干细胞生长出更多的血细胞。使用脐带血细胞可以降低移植物抗宿主病的风险。研究人员正在寻找将脐带血用于骨髓移植的最佳方法,并寻找在移植后追踪这些细胞的新方法。
  • 扩展骨髓移植的适应症。研究人员正在研究如何将这种疗法用于更广泛的疾病,包括复杂和罕见的疾病。
  • 新药物选择。妙佑医疗国际的研究人员正在研究骨髓移植患者的用药和治疗,包括使用哪些新药来帮助患者在骨髓移植后保持健康。
  • 缩短住院时间。在妙佑医疗国际,有些骨髓移植是在医院门诊进行的,这可缩短住院时间。

全国公认的专业实力

妙佑医疗国际的骨髓移植专家因其知识、经验和专业知识而广受赞誉。

Mayo Clinic in Rochester, Minn., Mayo Clinic in Phoenix/Scottsdale, Ariz., and Mayo Clinic in Jacksonville, Fla., are ranked among the Best Hospitals for cancer by U.S. News & World Report.

在妙佑医疗国际的体验与患者故事

患者告诉我们,互动质量、关注细节以及就医效率都是他们从未经历过的医疗体验。查看妙佑医疗国际满意患者的故事。

  1. Lisa_Miller-featured.jpg

    A new lease on life thanks to research into rare neurodegenerative disease

    The changes were subtle at first. "Almost unnoticeable," says Lisa Miller, remembering the symptoms that seemed to appear suddenly in late 2017. At a friend's wedding, the Front Royal, Virginia, project engineer remembers falling out of her shoes. "My left heel kept coming out from my shoes," she says. She chalked it up to too much merriment. A few months later, a co-worker told Lisa her gait was off and that she was dragging her…

  2. Felicia-bell-featured.jpg

    Diversity in bone marrow transplantation gives gift of life to mom of five

    Family is everything to Felicia Curtis. The mom of five from Gainesville, Florida, knew she had to fight when she was diagnosed with non-Hodgkin's lymphoma in 2017, when she was 20 weeks pregnant with her youngest child. Over the next several months, Felicia underwent several rounds of chemotherapy to fight the cancer. Her son was born healthy at 33 weeks. The future was bright. But six months later, the cancer returned, and doctors said the…

  3. Arneson-featured.jpg

    "Divine design" gives multiple myeloma patient transplant, care at home

    Ann Arneson describes her journey to Mayo Clinic as “divine design.” Ann — a retired teacher, a leader in her church and ministry, mother, grandmother, and line dance enthusiast — is Mayo Clinic’s first bone marrow transplant patient to recover at home thanks to the new advanced care at home program. “I know that people and circumstances are not by chance, but for a purpose — part of a bigger plan,” says Ann. A brush…

  4. Innovative transplant offers hope for patient with rare autoimmune disorder, few options

    Faced with a condition that has no cure and few treatment options, Chris Ryals turned to Mayo Clinic in Florida for an answer. An innovative transplant essentially reversed his symptoms and gave him hope. As a career military man, Chris Ryals was used to being physically active. The Air Force master sergeant ran regularly, visited [...]

专长与排名

妙佑医疗国际专家们一起工作的照片 值得信赖的经验

妙佑医疗国际的专家们通力合作,运用他们的知识和经验为骨髓移植患者提供最有效的治疗。这些经验和专业技能为妙佑医疗国际的医生们赢得了全球同行的尊重。

每年,妙佑医疗国际的医生都会诊断和治疗成千上万患有血液或骨髓疾病的患者,其中许多患者都受益于骨髓移植。妙佑医疗国际的骨髓移植项目是美国国内规模最大的骨髓移植项目之一。

妙佑医疗国际因在骨髓移植方面的卓越成就而受到国内和国际组织的认可:

了解更多关于妙佑医疗国际质量排名的信息。

治疗结局

 

妙佑医疗国际医生在移植方面拥有丰富经验和综合团队方案,让移植结果优于全国平均水平。团队在术前、术中和术后都与移植受者共同合作,以确保实现最佳效果。

妙佑医疗国际三个院区的数量和结果数据均分开保存。无论是综合进行,还是单独采用,妙佑医疗国际的移植受者都能获得极佳的治疗效果。

资格

如果您的骨髓功能异常或不能产生健康的干细胞,您可以选择骨髓移植。骨髓移植被用来治疗因疾病或治疗而导致干细胞受损的患者,或者作为一种让供体的免疫系统对抗血液疾病(如白血病)的方法。

医生将决定骨髓移植是否对您安全有益。您的治疗团队将阐述骨髓移植的益处和风险。

您的治疗团队还将对您进行评估,以确定骨髓移植或替代疗法是否是最适合您的治疗方案。

了解更多关于妙佑医疗国际骨髓移植资格 的信息。

位置、旅行和住宿

The Village at Mayo Clinic in Phoenix, Arizona, offers low-cost housing for transplant patients and their caregivers.

The Gabriel House of Care in Jacksonville, Florida, offers low-cost housing for transplant patients and their caregivers.

The Gift of Life Transplant House in Rochester, Minnesota, offers low-cost housing for transplant patients and their caregivers.

Mayo Clinic 在亚利桑那州的凤凰城和斯克茨戴尔、佛罗里达州的杰克逊威尔,以及明尼苏达州的罗切斯特都有主要院区。Mayo Clinic 健康系统在几个州拥有十几个工作地点。

有关参观 Mayo Clinic 的更多信息,请在下面选择您的位置:

费用与保险

骨髓移植的费用和保险信息

妙佑医疗国际有专门的移植经济服务代表和社工,可以为您提供有关移植的保险和财务方面的协助。

妙佑医疗国际与数百家保险公司合作,是数百万人的网络内医疗服务提供者。在大多数情况下,妙佑医疗国际不需要医师转诊。某些保险公司要求转诊,或有其他特定医疗护理方面的要求。许多保险公司要求您在移植服务之前获得预先批准。

保险信息

在进行移植之前,与保险公司密切合作,以了解您的保险给付计划很重要。您将承担所有不在保险公司承保范围内的移植和医疗护理费用。

关于移植费用,患者可能需要询问保险公司几个问题,包括:

  • 保险计划的具体承保范围是什么?对于医疗和移植服务,免赔额、共同保险、共付额、终身最高保额和年度最高金额是多少?
  • 我的福利计划是否包含预先存在或等待期条款?如有,时间框架是什么?是否可以豁免?
  • 我的保险计划是否涵盖药房保险?如有,保险计划是否报销目前使用的药物和免疫抑制剂用药?
  • 保险计划在评估或移植时是否需要任何特殊批准?一旦提交给保险公司,该批准过程需要多长时间?
  • 保险计划是否报销移植护理期间的交通和住宿费用?
  • 符合条件时,目前的保险是否需要投保联邦医疗保险?
  • 保险是否遵循联邦医疗保险福利协调指南?
  • 参保联邦医疗保险后,当前的承保范围将有何变化?我的保险计划是否会变成补充保险计划或是二级保险计划?

如果保险计划是联邦医疗保险辅助保险计划,请询问以下几个问题:

  • 保险计划是否遵循联邦医疗保险指南?
  • 保险计划是否报销联邦医疗保险 A 和 B 部分的免赔额和共保额?
  • 保险计划是否包含预先存在或等待期?如有,时间框架是什么?
  • 保险计划是否提供联邦医疗保险 D 部分承保范围的选项?

其他费用

请规划可能与您的移植相关的其他费用,其中可能包括随访复诊、长期药物治疗、照料者费用、差旅、停车、住宿和其他费用。

如果您进行了同种异体骨髓移植,则您的保险公司可能会支付与供体有关的移植相关医疗费用。

对于国际患者

妙佑医疗国际拥有专业的国际患者客户代表,他们可以帮助您解决有关费用和保险的问题。了解更多关于国际金融服务的信息。

病例管理员

妙佑医疗国际的财务人员将与您的保险公司的病例管理员紧密合作。指派给您的病例管理员可以回答与您的保险费用有关的问题和电话。

临床试验

探索 Mayo Clinic 的研究 测试新的治疗、干预与检查方法,旨在预防、检测、治疗或控制这种疾病。

Jan. 13, 2022
  1. AskMayoExpert. Hematopoietic stem cell transplant. Mayo Clinic; 2019.
  2. Hoffman R, et al. Overview of hematopoietic stem cell transplantation. In: Hematology: Basic Principles and Practice. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 2013. http://www.clinicalkey.com. Accessed July 8, 2016.
  3. Blood-forming stem cell transplants. National Cancer Institute. http://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant/stem-cell-fact-sheet. Accessed July 8, 2016.
  4. Majhail NS, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation. 2012;18:348.
  5. Diseases treatable by transplants. National Marrow Donor Program. https://bethematch.org/transplant-basics/how-transplants-work/diseases-treatable-by-transplants/. Accessed Aug. 1, 2019.
  6. AskMayoExpert. Graft-versus-host disease. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
  7. Blood and marrow stem cell transplantation. Leukemia & Lymphoma Society. https://www.lls.org/resource-center/download-or-order-free-publications. Accessed Aug. 1, 2019.
  8. Barbara Woodward Lips Patient Education Center. Autologous stem cell transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
  9. Blood and bone marrow transplant. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/blood-and-bone-marrow-transplant. Accessed Aug. 13, 2019.
  10. D'Souza A, et al. Current use and trends in hematopoietic cell transplantation in the United States. Biology of Blood and Marrow Transplantation. 2017; doi:10.1016/j.bbmt.2017.05.035.
  11. Jagasia MH, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: The 2014 Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation. 2015; doi:10.1016/j.bbmt.2014.12.001.
  12. Blood and marrow transplant (BMT): An introduction to allogeneic BMT. Leukemia & Lymphoma Society. https://www.lls.org/resource-center/download-or-order-free-publications. Accessed Aug. 1, 2019.
  13. Majhail NS. Long term complications after hematopoietic cell transplantation. Hematology Oncology Stem Cell Therapy. 2017; doi:10.1016/j.hemonc.2017.05.009.
  14. Hashmi SK, et al. National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group report. Biology of Blood and Marrow Transplantation. 2017; doi:10.1016/j.bbmt.2016.09.025.
  15. DeFilipp Z, et al. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: Screening and preventive practice recommendations from CIBMTR and EBMT. Biology of Blood and Marrow Transplantation. 2016; doi:10.1038/bmt.2016.203.
  16. Mills SD, et al. Bone-marrow transplant in an identical twin. JAMA. 1964; doi:10.1001/jama.1964.03060380005001.
  17. Rashidi A, et al. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood Advances. 2019; doi:10.1182/bloodadvances.2019000050.
  18. Ahmed S, et al. Lower graft-versus-host disease and relapse risk in post-transplant cyclophosphamide-based haploidentical versus matched sibling donor reduced-intensity conditioning transplant for Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 2019; doi:10.1016/j.bbmt.2019.05.025.
  19. Jain T, et al. Choosing a reduced-intensity conditioning regimen for allogeneic stem cell transplantation, fludarabine/busulfan versus fludarabine melphalan: A systematic review and meta-analysis. Biology of Blood and Marrow Transplantation. 2019; doi:10.1016/j.bbmt.2018.11.016.
  20. Chen YB, et al. Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. Blood Advances. 2019; doi:10.1182/bloodadvances.2018027599.
  21. Ballen KK, et al. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: Comparison among alternative graft sources. Biology of Blood and Marrow Transplantation. 2014; doi:10.1016/j.bbmt.2014.07.021.
  22. Sweeney SK, et al. Tracking embryonic hematopoietic stem cells to the bone marrow: Nanoparticle options to evaluate transplantation efficiency. Stem Cell Research & Therapy. 2018; doi:10.1186/s13287-018-0944-8.
  23. Kumar A, et al. Antithymocyte globulin for graft-versus-host disease prophylaxis: An updated systematic review and meta-analysis. Bone Marrow Transplantation. 2019; doi:10.1038/s41409-018-0393-0.
  24. Graff TM, et al. Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. Bone Marrow Transplant. 2015; doi: 10.1038/bmt.2015.46.
  25. Brown AY. Allscripts EPSi. Mayo Clinic. Sept. 16, 2019.
  26. Search for a FACT accredited organization. Foundation for the Accreditation of Cellular Therapy (FACT). http://accredited.factwebsite.org/. Accessed Aug. 13, 2019.
  27. Transplant center search results. Be The Match. https://bethematch.org/tcdirectory/search/advanced/#mayo/-/-/false/-.Accessed Aug. 13, 2019.
  28. Participating transplant centers. Center for International Blood and Marrow Transplant Research. https://www.cibmtr.org/About/WhoWeAre/Centers/Pages/index.aspx?country=us&state=Minnesota. Accessed Aug. 13, 2019.
  29. Locations. Children's Oncology Group. https://childrensoncologygroup.org/index.php/locations/. Accessed Aug. 13, 2019.
  30. Participating institutions. ECOG-ACRIN Cancer Research Group. https://ecog-acrin.org/participating-institutions. Accessed Aug. 13, 2019.
  31. PBMTC members. Pediatric Blood and Marrow Transplant Consortium. http://www.pbmtc.org/about/members/full. Accessed Aug. 13, 2019.
  32. Participating clinical centers. Primary Immune Deficiency Treatment Consortium. https://www.rarediseasesnetwork.org/cms/pidtc/Learn-More/Participating-Clinical-Centers. Accessed Aug. 13, 2019.

相关

产品与服务